Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liquidia Technologies Inc

24.36
+1.165.00%
Post-market: 25.000.6399+2.63%19:52 EDT
Volume:3.09M
Turnover:74.78M
Market Cap:2.10B
PE:-13.41
High:24.72
Open:23.39
Low:23.04
Close:23.20
52wk High:29.94
52wk Low:9.71
Shares:86.09M
Float Shares:60.05M
Volume Ratio:1.64
T/O Rate:5.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8167
EPS(LYR):-1.6567
ROE:-389.13%
ROA:-39.74%
PB:138.07
PE(LYR):-14.70

Loading ...

BRIEF-Liquidia Corp - Unit Enters Exclusive Licensing Agreement With Vectura - SEC Filing

Reuters
·
Oct 30

Liquidia Signs Exclusive Licensing Agreement With Vectura for Treprostinil Products in US

Reuters
·
Oct 30

Liquidia Technologies (LQDA) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Oct 29

Evaluating Liquidia (LQDA): Is the Current Valuation Justified by Its Recent Rally?

Simply Wall St.
·
Oct 29

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire
·
Oct 27

Liquidia Corporation CEO Roger Jeffs Reports Disposal of Common Shares

Reuters
·
Oct 16

Ionis, Jazz Named Top Picks as US Biopharma Heads Into Steady Q3, BofA Says

MT Newswires Live
·
Oct 09

BofA Adjusts Price Target on Liquidia to $37 From $35

MT Newswires Live
·
Oct 09

Liquidia price target raised to $37 from $35 at BofA

TIPRANKS
·
Oct 09

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

GlobeNewswire
·
Oct 07

Liquidia Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 06

BTIG biotech analyst holds an analyst/industry conference call

TIPRANKS
·
Oct 04

Liquidia Corporation to Present New ASCENT Trial Data on Inhaled Treprostinil for PH-ILD at CHEST 2025 Annual Meeting

Reuters
·
Sep 29

United Therapeutics' Tyvaso Success in IPF to Unlock Big Market Opportunity, RBC Says

MT Newswires Live
·
Sep 26

Liquidia Corporation's (NASDAQ:LQDA) institutional investors lost 9.0% over the past week but have profited from longer-term gains

Simply Wall St.
·
Sep 26

Liquidia Corporation Unveils Upcoming Data Presentations on YUTREPIA™ at PHPN Symposium for Pulmonary Hypertension Treatment

Reuters
·
Sep 11

Director Raman Singh Reports Disposal of Common Shares of Liquidia Corporation

Reuters
·
Sep 06

Director Paul B. Manning Reports Disposal of Common Shares of Liquidia Corporation

Reuters
·
Sep 03

Liquidia Corporation's Chief Business Officer Jason Adair Reports Disposal of Common Shares

Reuters
·
Sep 03

Rajeev Saggar, Chief Medical Officer, Reports Disposal of Common Shares of Liquidia Corporation

Reuters
·
Sep 03